

Overview
Type 2 Diabetes Mellitus (Type 2 DM) is one of the leading causes of non-communicable diseases in the world.
Suboptimal glycemic control can result in a multitude of complications. Despite the availability of
treatments, a significant number of patients continue to experience these complications. Early treatment
intensification in addition to lifestyle modification has been shown to reduce the risk of multiple
complications from the disease.
This online learning module delves into the updated guidelines and
explores the role of glucose like peptide (GLP-1) agonists in the management of Type 2 DM.
Upon completion of the e-learning module, participants should be able to: